Cite
MLA Citation
L. J. Nastoupil et al.. “P1455: FIRST-IN-HUMAN TRIAL OF CB-010, A CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR -T CELL THERAPY WITH A PD-1 KNOCK OUT, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA (ANTLER STUDY).” HemaSphere, vol. 6, n.d., pp. 1337–1338. http://access.bl.uk/ark:/81055/vdc_100159756069.0x000003